Catalog Number | : | CS-O-07867 |
---|---|---|
CAS Number | : | 66635-93-6 |
Status | : | Available for immediate dispatch |
List Price | Online Price | Size | Stock Status | Quantity | |
---|---|---|---|---|---|
![]() |
Chemical Name | : | (1R)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid |
---|---|---|
Category | : | Chiral |
Purity | : | 96.62 |
Synonyms | : | (R)-Ketorolac |
Molecular Weight | : | 255.27 mol/g |
Molecular Formula | : | C₁₅H₁₃NO₃ |
Application | : | NULL |
Therapeutic | : | Anti-Migraines |
Status: | : | Available for immediate dispatch |
---|---|---|
COA | : |
[Login Needed]
|
MSDS | : |
[Login Needed]
|
Hazardous Compound | : | Yes |
Payment mode | : | Credit / Debit / Purchase Order |
---|---|---|
Taxes | : | All prices are inclusive taxes |
Refund Policy | : | 30 days money back guarantee |
Ketorolac, sold under the brand names Toradol, and Biorolac among others, is a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain. Specifically it is recommended for moderate to severe pain. Recommended duration of treatment is less than six days. It is used by mouth, by nose, by injection into a vein or muscle, and as eye drops. Effects begin within an hour and last for up to eight hours.
Common side effects include sleepiness, dizziness, abdominal pain, swelling, and nausea. Serious side effects may include stomach bleeding, kidney failure, heart attacks, bronchospasm, heart failure, and anaphylaxis. Use is not recommended during the last part of pregnancy or during breastfeeding. Ketorolac works by blocking cyclooxygenase 1 and 2 (COX1 and COX2), thereby decreasing production of prostaglandins.
Ketorolac was patented in 1976 and approved for medical use in 1989. It is available as a generic medication. In 2018, it was the 192nd most commonly prescribed medication in the United States, with more than 3\u00a0million prescriptions.
References | : | "Fundinguniverse,com, Retrieved 2013-10-06; Lee, I, O,; Seo, Y, (2008)" |
---|---|---|
Canonical SMILES | : | C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O |
Isomeric SMILES | : | C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)[C@@H]1C(=O)O |
InChI | : | InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)/t11-/m1/s1 |
InchIKey | : | OZWKMVRBQXNZKK-LLVKDONJSA-N |
IUPAC Name | : | (1R)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid |
Exact Mass | : | 255.08954328 |
Description | : | (R)-ketorolac is a 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid that has R configuration. Unlike the S-enantiomer, it does not exhibit COX1 and COX2 inhibition, but does exhibit analgesic activity. Racemic ketorolac, known simply as ketorolac, is used (mainly as a tromethamine salt) as a potent analgesic for the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It has a role as an analgesic. It is an enantiomer of a (S)-ketorolac. |
CAT NO. | COMPOUND | CAS NO. | CATEGORY |
---|---|---|---|
CS-T-57027 | (S)-Ketorolac | 66635-92-5 | Chiral |